| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL
|
Kittai, Adam S.
|
|
|
8 |
11 |
p. 2861-2869
|
artikel
|
| 2 |
A temporal developmental map separates human NK cells from noncytotoxic ILCs through clonal and single-cell analysis
|
Vo, Dang Nghiem
|
|
|
8 |
11 |
p. 2933-2951
|
artikel
|
| 3 |
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis
|
Driessen, Julia
|
|
|
8 |
11 |
p. 2740-2752
|
artikel
|
| 4 |
CAR-T for large B-cell lymphomas: the clock is ticking
|
Chong, Elise A.
|
|
|
8 |
11 |
p. 2980-2981
|
artikel
|
| 5 |
CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy
|
Guo, Shanshan
|
|
|
8 |
11 |
p. 2635-2645
|
artikel
|
| 6 |
Clinical and treatment characteristics of infants and toddlers less than 2 years of age with hemophilia
|
Han, Jennifer H.
|
|
|
8 |
11 |
p. 2707-2717
|
artikel
|
| 7 |
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia
|
Wang, Daniel
|
|
|
8 |
11 |
p. 2835-2845
|
artikel
|
| 8 |
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease
|
Jalink, Marit
|
|
|
8 |
11 |
p. 2622-2634
|
artikel
|
| 9 |
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
|
Gentile, Gaia
|
|
|
8 |
11 |
p. 2846-2860
|
artikel
|
| 10 |
Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice
|
Cuker, Adam
|
|
|
8 |
11 |
p. 2960-2963
|
artikel
|
| 11 |
Enhanced MAPK signaling induced by CSF3R mutants confers dependence to DUSP1 for leukemic transformation
|
Kesarwani, Meenu
|
|
|
8 |
11 |
p. 2765-2776
|
artikel
|
| 12 |
Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy
|
Han, Huixiu
|
|
|
8 |
11 |
p. 2675-2690
|
artikel
|
| 13 |
Fibrinogen levels and clot properties identify patients who benefit from catheter-directed thrombolysis after DVT
|
Iding, Aaron F. J.
|
|
|
8 |
11 |
p. 2924-2932
|
artikel
|
| 14 |
Hemojuvelin-mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3
|
Dogan, Deniz Y.
|
|
|
8 |
11 |
p. 2870-2879
|
artikel
|
| 15 |
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria
|
Peffault de Latour, Régis
|
|
|
8 |
11 |
p. 2718-2725
|
artikel
|
| 16 |
Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study
|
Heald, James S.
|
|
|
8 |
11 |
p. 2691-2694
|
artikel
|
| 17 |
Immune milestones to predict CMV after letermovir
|
Little, J. S.
|
|
|
8 |
11 |
p. 2964-2966
|
artikel
|
| 18 |
Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A
|
Horling, Frank M.
|
|
|
8 |
11 |
p. 2726-2739
|
artikel
|
| 19 |
Impaired T cells and “memory-like” NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation
|
Lauruschkat, Chris David
|
|
|
8 |
11 |
p. 2967-2979
|
artikel
|
| 20 |
Machine learning to optimize automated RH genotyping using whole-exome sequencing data
|
Chang, Ti-Cheng
|
|
|
8 |
11 |
p. 2651-2659
|
artikel
|
| 21 |
Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications
|
Letouzé, Eric
|
|
|
8 |
11 |
p. 2952-2959
|
artikel
|
| 22 |
Neutrophil functions in patients with neutropenia due to glycogen storage disease type 1b treated with empagliflozin
|
Kaczor, Magdalena
|
|
|
8 |
11 |
p. 2790-2802
|
artikel
|
| 23 |
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival
|
Shimony, Shai
|
|
|
8 |
11 |
p. 2803-2812
|
artikel
|
| 24 |
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7
|
Ghobadi, Armin
|
|
|
8 |
11 |
p. 2982-2990
|
artikel
|
| 25 |
PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation
|
Chmiest, Daniela
|
|
|
8 |
11 |
p. 2908-2923
|
artikel
|
| 26 |
Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria
|
Chonat, Satheesh
|
|
|
8 |
11 |
p. 2813-2824
|
artikel
|
| 27 |
Pooled analysis of pralatrexate single-agent studies in patients with relapsed/refractory peripheral T-cell lymphoma
|
O’Connor, Owen A.
|
|
|
8 |
11 |
p. 2601-2611
|
artikel
|
| 28 |
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort
|
Hassan, Shermarke
|
|
|
8 |
11 |
p. 2880-2889
|
artikel
|
| 29 |
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis
|
Arcudi, Sara
|
|
|
8 |
11 |
p. 2901-2907
|
artikel
|
| 30 |
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia
|
Nilius, Henning
|
|
|
8 |
11 |
p. 2825-2834
|
artikel
|
| 31 |
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation
|
Fingrut, Warren B.
|
|
|
8 |
11 |
p. 2753-2764
|
artikel
|
| 32 |
Röth A, Broome CM, Barcellini W, et al. Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up. Blood Adv. 2023;7(19):5890-5897.
|
|
|
|
8 |
11 |
p. 2650
|
artikel
|
| 33 |
SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow
|
Allaeys, Isabelle
|
|
|
8 |
11 |
p. 2777-2789
|
artikel
|
| 34 |
Semaphorin 7A coordinates neutrophil response during pulmonary inflammation and sepsis
|
Granja, Tiago
|
|
|
8 |
11 |
p. 2660-2674
|
artikel
|
| 35 |
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
|
Lübke, Johannes
|
|
|
8 |
11 |
p. 2890-2900
|
artikel
|
| 36 |
Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia
|
De Coninck, Stien
|
|
|
8 |
11 |
p. 2646-2649
|
artikel
|
| 37 |
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm
|
Bataller, Alex
|
|
|
8 |
11 |
p. 2695-2706
|
artikel
|
| 38 |
Trajectories of physical well-being among adults with acute myeloid leukemia
|
Jensen-Battaglia, Marielle
|
|
|
8 |
11 |
p. 2612-2621
|
artikel
|
Tijdschrift beschrijving